Portugalโs Golden Gate Bridge ๐คฉ
17.06.2025 08:11 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0@drrobinreschke.bsky.social
Max-Eder Research Group Leader & Physician Scientist @NCT @DKFZ @DKTK @Uniklinik_HD TRYTRAC @CancerCoreEurope before PostDoc @Uchicago Gajewski lab #skin #cancer #immunology #spatialbiology #dermatology
Portugalโs Golden Gate Bridge ๐คฉ
17.06.2025 08:11 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0โจ Grateful for the opportunity to present some data from my lab today at #EACR2025 in Lisbon! ๐งฌ๐ฌ๐ต๐น
It was a pleasure to engage with such an inspiring community of researchers.๐ก๐ Thanks to everyone who stopped by, asked questions, and shared ideas โ exciting things ahead! ๐
@helloeacr.bsky.social
First time at #EACR โ excited to kick off this incredible meeting in beautiful Lisbon! Let the science (and sunshine) begin โ๏ธ๐ต๐น
@EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social
Feeling very grateful! ๐คฉ๐
A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) ๐ฅ๐ ๐
Thank you! It was an amazing first SID meeting for me :)
10.05.2025 16:32 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0Stellar Keynote lecture from Laura Mackay on TRM cell fate at #SID25 in San Diego @siderm.bsky.social ๐ค๐คฉ๐
10.05.2025 15:39 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0Great experience and stellar scientific meeting ๐
09.05.2025 23:57 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0Big thanks to the Society for Investigative Dermatologyย for an amazing meeting in San Diego so far! Honored to receive an award for our work and the invitation to present ๐ฅณGrateful for the inspiring science, conversations, and community! โ๏ธ#SID2025#DermResearchย
@siderm.bsky.social
Auftakt fรผr TRYTRAC, das europรคische Nachwuchsprogramm von Cancer Core Europe (CCE): Junge Wissenschaftler:innen aus sieben Top-Krebszentren โ darunter vier Fellows aus Heidelberg โ trafen sich am Karolinska Institutet in Stockholm.
๐ www.nct-heidelberg.de/das-nct/news...
Recommended ๐ โAdiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicitiesโ @natureportfolio.nature.com co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social
๐ www.nature.com/articles/s41...
๐จNew research highlight: study on managing immunotherapy side effects without weakening anti-tumor power!
ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin.
Promising results from Zeiser et al. ๐ฌ ๐งช ๐งซ
Full summary:
www.nature.com/articles/s41...
Thanks for sharing our manuscript @cancercoreeurope.bsky.social ๐
28.01.2025 14:33 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0๐ โTargeting molecular pathways to control immune checkpoint inhibitor toxicitiesโ co-authored by @drrobinreschke.bsky.socialย from @nct-heidelberg.bsky.socialย @dkfz.bsky.socialย
๐ https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0
Heidelberg is placing first when it comes to #startup founders per capita in #Germany. With 13.5 new startups per 100.000 inhabitants in 2024, Heidelberg is outperforming startup hotspots such as #Berlin and #Munich.
The full report is here:
startupverband.de/fileadmin/st...
Now featured and OPEN ACCESS ๐ซ๐๐ป๐
15.01.2025 17:11 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0The article is now featured and OPEN ACCESS ๐ซ
15.01.2025 15:54 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0The article is now featured and OPEN ACCESS ๐ซ
15.01.2025 15:53 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0The article is now featured and OPEN ACCESS ๐ซ๐๐ป
www.cell.com/trends/immun...
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
@drrobinreschke.bsky.social
@jhu.edu @harvard.edu
oncodaily.com/science/immu...
#Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health
Thanks for sharing ๐
30.12.2024 08:45 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0Comprehensive interdisciplinary review on current and emerging therapeutic targets to treat immune-related adverse events (irAE). A rapidly evolving field of high clinical relevance elegantly summarized by Jessica Hassel and colleagues @dkfz.bsky.social @cellpress.bsky.social doi.org/10.1016/j.it...
30.12.2024 08:08 โ ๐ 5 ๐ 3 ๐ฌ 1 ๐ 0Review: Targeting molecular pathways to control immune checkpoint inhibitor toxicities
www.cell.com/trends/immun...
Hot off the press ๐ฅ
Very proud of this collaboration! ๐ซ
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? ๐ค
This is a must-read ๐คฉ
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
โ ๏ธ Anti-PD1 therapy could serve as an effective systemic treatment for patients with basal cell nevus syndrome who are resistant to hedgehog inhibitors, leveraging the immune system to address new occurrences of basal cell carcinoma ๐ก๐ง ๐ฌ.
๐ Read the full study here:
jamanetwork.com/journals/jam...
๐ Our latest article gives an update about prognostic biomarkers in evolving melanoma immunotherapy: From PD-L1 to gut microbiota and beyond ๐งฌ๐
Enjoy the weekend read ๐ : link.springer.com/article/10.1...
๐ #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology
---
What an amazing Secret Santa exchange on the lab floor! ๐คฉ๐๐ So much laughter, surprises, and holiday cheer โ can't wait to do it again next year! โจ๐ @nct-heidelberg.bsky.social
20.12.2024 17:20 โ ๐ 5 ๐ 0 ๐ฌ 0 ๐ 0Congrats ๐คฉ
16.12.2024 18:18 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0Please add me :)
15.12.2024 19:54 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0No problem ๐
15.12.2024 18:02 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0